Vertex Pharmaceuticals Incorporated (VRTX)
NASDAQ: VRTX · Real-Time Price · USD
455.48
-1.88 (-0.41%)
At close: Dec 5, 2025, 4:00 PM EST
455.97
+0.49 (0.11%)
After-hours: Dec 5, 2025, 7:46 PM EST
Vertex Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 115,564 | 103,707 | 104,849 | 74,127 | 55,834 | 61,457 | |
| Market Cap Growth | -3.91% | -1.09% | 41.44% | 32.76% | -9.15% | 9.16% | |
| Enterprise Value | 105,389 | 94,253 | 91,965 | 65,181 | 49,750 | 55,853 | |
| Last Close Price | 455.48 | 402.70 | 406.89 | 288.78 | 219.60 | 236.34 | |
| PE Ratio | 32.02 | - | 28.97 | 22.31 | 23.84 | 22.66 | |
| Forward PE | 22.77 | 22.66 | 24.44 | 18.83 | 16.42 | 21.78 | |
| PS Ratio | 9.97 | 9.41 | 10.62 | 8.30 | 7.37 | 9.90 | |
| PB Ratio | 6.68 | 6.32 | 5.96 | 5.33 | 5.53 | 7.08 | |
| P/TBV Ratio | 7.31 | 7.15 | 6.70 | 6.07 | 6.42 | 8.44 | |
| P/FCF Ratio | 34.63 | - | 31.42 | 18.89 | 23.18 | 20.53 | |
| P/OCF Ratio | 31.08 | - | 29.64 | 17.95 | 21.12 | 18.89 | |
| PEG Ratio | 0.08 | 1.21 | 1.92 | 0.58 | 1.62 | 1.06 | |
| EV/Sales Ratio | 8.99 | 8.55 | 9.32 | 7.30 | 6.57 | 9.00 | |
| EV/EBITDA Ratio | 22.37 | 20.59 | 20.54 | 14.40 | 12.38 | 17.66 | |
| EV/EBIT Ratio | 23.23 | 21.45 | 21.35 | 14.89 | 12.78 | 18.29 | |
| EV/FCF Ratio | 31.58 | - | 27.56 | 16.61 | 20.66 | 18.66 | |
| Debt / Equity Ratio | 0.11 | 0.11 | 0.05 | 0.07 | 0.10 | 0.11 | |
| Debt / EBITDA Ratio | 0.37 | 0.37 | 0.18 | 0.20 | 0.24 | 0.30 | |
| Debt / FCF Ratio | 0.55 | - | 0.24 | 0.23 | 0.40 | 0.32 | |
| Asset Turnover | 0.50 | 0.49 | 0.48 | 0.57 | 0.60 | 0.62 | |
| Inventory Turnover | 4.10 | 5.31 | 7.38 | 8.87 | 8.97 | 10.62 | |
| Quick Ratio | 1.84 | 2.17 | 3.60 | 4.46 | 4.04 | 4.02 | |
| Current Ratio | 2.36 | 2.69 | 3.99 | 4.83 | 4.46 | 4.33 | |
| Return on Equity (ROE) | 22.31% | -3.15% | 22.99% | 27.67% | 24.93% | 36.71% | |
| Return on Assets (ROA) | 12.04% | 12.14% | 13.17% | 17.33% | 19.32% | 19.02% | |
| Return on Capital (ROIC) | 15.51% | 15.03% | 16.22% | 21.15% | 23.51% | 23.29% | |
| Return on Capital Employed (ROCE) | 22.30% | 23.20% | 22.50% | 28.40% | 34.50% | 30.90% | |
| Earnings Yield | 3.18% | -0.52% | 3.45% | 4.48% | 4.20% | 4.41% | |
| FCF Yield | 2.89% | -0.76% | 3.18% | 5.29% | 4.31% | 4.87% | |
| Buyback Yield / Dilution | -0.11% | 1.00% | -0.54% | 0.31% | 1.33% | -1.04% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.